Mikkael A. Sekeres, MD, MS
Director, Leukemia Program
Vice Chair for Clinical Research
Dr. Mikkael Sekeres earned a medical degree and a master’s degree in clinical epidemiology from the University of Pennsylvania School of Medicine. He completed his postgraduate training at Harvard University, finishing an internal medicine residency at Massachusetts General Hospital, and a fellowship in hematology-oncology at the Dana-Farber Cancer Institute in Boston. Dr. Sekeres is Professor of Medicine, Director of the Leukemia Program, and Vice Chair for Clinical Research at the Cleveland Clinic Taussig Cancer Institute. In addition, he is Deputy Associate Director for Clinical Research of the Case Comprehensive Cancer Center in Ohio.
Dr. Sekeres chaired the Oncologic Drugs Advisory Committee of the FDA and is co-chair of the medical advisory board of the Aplastic Anemia and Myelodysplastic Syndromes (MDS) International Foundation. He is a member of the American Society of Hematology, the American Society of Clinical Oncology, and the Southwest Oncology Group—Leukemia Committee. Dr. Sekeres is an invited speaker at numerous meetings, grand rounds, and conferences. He is the author/co-author of hundreds of abstracts published in Blood, Journal of Clinical Oncology, Nature Genetics, Journal of the National Cancer Institute, PLoS One, Cancer, Haematologica, and Leukemia. He is also the co-author of six books, editor-in-chief of the ASH Clinical News magazine, is on the editorial board of several journals, and is an essayist for The New York Times and Huffington Post. Dr. Sekeres’ current research focuses on patients with MDS and older adults with acute myeloid leukemia, and he has been the national primary study investigator on several phase I/II trials.